Yeah, I feel kind of lucky these days, now that mitochondria seems to be at the center of every possible "aging" disease. Something good will happen sooner or later.
The next milestone is the approval of EPI-743[1]. Phase III trials have just finished and data is being gathered and analyzed. If everything works out fine, we could see actual prescriptions of the drug one year from now.
Speaking of LHON, take a look at the impressive results[2] of this drug with LHON patients.
The most promising sign is the metasign - that we can compare and contrast so many different approaches, and complain because some are not getting more attention. Yet overall things are happening.
[1] http://www.sciencemag.org/content/314/5798/471